Tristel plc (FRA:R1V)

Market Cap	222.31M +9.0%
Revenue (ttm)	54.20M +10.8%
Net Income	7.75M +2.3%
EPS	0.16 +2.1%
Shares Out	n/a
PE Ratio	28.70
Forward PE	23.67
Dividend	0.16 (3.68%)
Ex-Dividend Date	Nov 27, 2025

Volume	n/a
Average Volume	13
Open	4.480
Previous Close	4.480
Day's Range	4.480 - 4.480
52-Week Range	3.040 - 5.050
Beta	n/a
RSI	43.38
Earnings Date	Mar 2, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1993
• Employees: 267
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R1V

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Financial numbers in GBP